Clinical Trial Update: Vildagliptin and Endothelium-dependent Vasodilatation [Phase 3]

View source ↗

Summary

A Phase 3 trial update on vildagliptin assessing endothelium-dependent vasodilatation in type 2 diabetes with endothelial dysfunction; the study status is compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endothelial Dysfunction
• Type 2 Diabetes Mellitus

Drugs mentioned

• Vildagliptin (vildagliptin)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Type 2 Diabetes, Endothelial Dysfunction | Phase 3 | Status: COMPLETED